Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier.

Recent clinical trials indicate the efficacy of interferon (IFN)-beta 1b in reducing relapse rate in relapsing-remitting multiple sclerosis (MS), whereas a surge of IFN-gamma precedes and provokes acute relapses. Disruption of the cerebral endothelial barrier and transendothelial migration of inflammatory cell migration into the brain play a significant role in pathogenesis of MS and may be driven by this surge in IFN-gamma. However, the molecular mechanisms underlying the beneficial effects of IFN-beta 1b against the deleterious effects of IFN-gamma on the barrier formed by the junctional proteins remain to be characterized. The authors investigated the effects of IFN-beta 1b, IFN-beta 1a, and IFN-gamma on the integrity of two endothelial junctional proteins, occludin and vascular endothelial-cadherin (VE-cadherin). Human umbilical vein endothelial cell (HUVEC) layers were treated with IFN-beta 1b, IFN-beta 1a, IFN-gamma, IFN-beta 1b plus IFN-gamma, or IFN-beta 1a plus IFN-gamma. IFN-beta 1b, IFN-beta 1a, and IFN-gamma effects on occludin and VE-cadherin integrity and electrical resistance were assessed by Western blotting and immunofluorescence. IFN-gamma significantly reduced occludin expression and produced gaps in endothelial monolayers. VE-cadherin expression was decreased to a lesser extent in endothelial cells exposed to IFN-gamma. IFN-beta 1b significantly attenuated the IFN-gamma-induced decrease in occludin and VE-cadherin expression. The protective effects of IFN-beta 1a on IFN-gamma-treated endothelial cells were similar to those of IFN-beta 1b. IFN-gamma also significantly reduced endothelial monolayer electrical resistance; this effect was blocked by either IFN-beta 1a or IFN-beta 1b. IFN-beta 1a and IFN-beta 1b effectively prevent the IFN-gamma-induced disintegration of the endothelial tight junctions and sustain barrier against the effects of IFN-gamma. The protective effects of IFN-beta on occludin and VE-cadherin stability appear to represent molecular mechanisms for the therapeutic effects of the IFN-beta on blood brain barrier in MS.

[1]  A. Minagar,et al.  Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells , 2003, Multiple sclerosis.

[2]  E. Waubant,et al.  IFNβ lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS , 2003, Neurology.

[3]  A. Minagar,et al.  Elevated plasma endothelial microparticles in multiple sclerosis , 2001, Neurology.

[4]  J. Tonn,et al.  Production of MMPs in Human Cerebral Endothelial Cells and Their Role in Shedding Adhesion Molecules , 2001, Journal of neuropathology and experimental neurology.

[5]  P Bacchetti,et al.  Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. , 1999, Neurology.

[6]  M. Corada,et al.  Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Hordijk,et al.  Vascular-endothelial-cadherin modulates endothelial monolayer permeability. , 1999, Journal of cell science.

[8]  O. Stuve,et al.  Interferon beta in the treatment of multiple sclerosis , 1998, Neurology.

[9]  G. Bieler,et al.  Pulse treatment of human vascular endothelial cells with high doses of tumor necrosis factor and interferon‐gamma results in simultaneous synergistic and reversible effects on proliferation and morphology , 1998, International journal of cancer.

[10]  J. Alexander,et al.  Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins* , 1998, The Journal of Biological Chemistry.

[11]  S. Dhib-jalbut,et al.  Mechanisms of interferon beta action in multiple sclerosis , 1997, Multiple sclerosis.

[12]  S I Simon,et al.  Neutrophil transendothelial migration is independent of tight junctions and occurs preferentially at tricellular corners. , 1997, Journal of immunology.

[13]  F. Haselton,et al.  Role of cadherins 5 and 13 in the aortic endothelial barrier , 1997, Journal of cellular physiology.

[14]  S. Dhib-jalbut,et al.  The effect of interferon β-1b on lymphocyte-endothelial cell adhesion , 1996, Journal of Neuroimmunology.

[15]  M. Corada,et al.  Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions , 1996, The Journal of cell biology.

[16]  C. Brosnan,et al.  Mechanisms of Immune Injury in Multiple Sclerosis , 1996, Brain pathology.

[17]  C. Granger,et al.  Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis , 1996, Annals of neurology.

[18]  K. Fujimoto,et al.  Overexpression of occludin, a tight junction-associated integral membrane protein, induces the formation of intracellular multilamellar bodies bearing tight junction-like structures. , 1996, Journal of cell science.

[19]  K. Fujimoto.  Freeze-fracture replica electron microscopy combined with SDS digestion for cytochemical labeling of integral membrane proteins. Application to the immunogold labeling of intercellular junctional complexes. , 1995, Journal of cell science.

[20]  M. Corada,et al.  Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[21]  U. Michel,et al.  Cerebral endothelial cells are a major source for soluble intercellular adhesion molecule-1 in the human central nervous system , 1995, Neuroscience Letters.

[22]  D. Paty,et al.  Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule‐1 in cultured fetal human astrocytes , 1995, Neurology.

[23]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[24]  T. Springer.  Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[25]  M. Itoh,et al.  Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.

[26]  G. Grau,et al.  Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis. , 1992, European cytokine network.

[27]  R. Hirsch,et al.  Treatment of multiple sclerosis with gamma interferon , 1987, Neurology.

[28]  D. Granger,et al.  Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. , 2001, Microvascular research.

[29]  S I Simon,et al.  Analysis of tight junctions during neutrophil transendothelial migration. , 2000, Journal of cell science.